
a
a
a

• Complications related to motherhood, particularly in high-risk pregnancies, often lack real-time molecular monitoring
• The lack of continuous monitoring tools prevents early diagnosis and rapid intervention
• The current maternal care system does not take advantage of personalised molecular data, relegating prevention to a secondary role
• Development of molecular wearables, non-invasive portable devices that continuously measure chemical (proteins, hormones, etc.) and biophysical biomarkers
• Combination of personalised biological analysis and artificial intelligence to provide proactive maternal care tailored to each user
• Continuous remote monitoring to improve clinical diagnosis, reduce maternal complications and promote well-being during pregnancy
• In progress
• In progress